KRT19 Antibody / Cytokeratin 19 | V2680-100UG

KRT19 Antibody / Cytokeratin 19 | V2680-100UG | Gentaur US, UK & Europe Disrtribition

Family: Primary antibody

Formulation: 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide

Format: Purified

Clone: Ks19.1

Host Animal: Mouse

Clonality: Monoclonal (mouse origin)

Species Reactivity: Human

Application: WB, IF, IHC-P

Buffer: N/A

Limitation: This KRT19 antibody is available for research use only.

Purity: Protein G affinity chromatography

Description: This mAb reacts with the rod domain of human cytokeratin-19 (CK19), a polypeptide of 40kDa. Its epitope maps between amino acid 312-335. CK19 is expressed in sweat gland, mammary gland ductal and secretory cells, bile ducts, gastrointestinal tract, bladder urothelium, oral epithelia, esophagus, and ectocervical epithelium. Anti-CK19 reacts with a wide variety of epithelial malignancies including adenocarcinomas of the colon, stomach, pancreas, biliary tract, liver, and breast. Perhaps the most useful application is the identification of thyroid carcinoma of the papillary type, although 50%-60% of follicular carcinomas are also labeled. Anti-CK19 is a useful marker for detection of tumor cells in lymph nodes, peripheral blood, bone marrow and breast cancer.

Immunogen: Human breast cancer MCF-7 cells were used as the immunogen for the KRT19 antibody.

Storage: Store the KRT19 antibody at 2-8oC (with azide) or aliquot and store at -20 °C or colder (without azide).